St. Jude granted European approval for new lead delivery system

May 27, 2010 by MedCity News

St. Jude Medical wins CE Mark approval to begin selling and marketing the latest version of its Epiducer lead delivery system.

MedCity News logo

By Brandon Glenn

St. Jude Medical (NYSE:STJ) has received European regulatory approval to begin selling the next-generation version of its Epiducer lead delivery system.

Leads are wires containing electrodes that deliver electrical shocks from neurostimulators, which use electricity to block the transmission of pain signals to the brain in patients suffering from chronic pain.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp